Let us show you how we used our proprietary advanced analytics, hyper-targeted media, and digital efforts to help a P2-positioned brand achieve a 30% increase in NRx and a 10-point gain in market share.
Everyone deserves better health. Read More »
Let us show you how we used our proprietary advanced analytics, hyper-targeted media, and digital efforts to help a P2-positioned brand achieve a 30% increase in NRx and a 10-point gain in market share.
It’s time to start taking things non-personally. Read More »
Let us show you how we used data-driven intelligence and strategic scenario planning to help deliver a flawless launch for a new biologic making its dynamic debut. The launch was so successful it transitioned our client from being a peripheral player to a category leader.
Let us show you how we used advanced analytics and killer insight to lift a steadily declining legacy brand to its highest growth rate in NBRx share in 5 years.
Does your brand need another bounce? Read More »
Let us show you how we used advanced analytics to find insights that dramatically increased a client’s campaign performance and increased ROI 7:1.
Had enough media mediocrity? Read More »
Despite clinical acceptance of the efficacy of long-acting injectables (LAIs) to provide prolonged stability for people suffering from schizophrenia, they still only make up about 13% of the market. Psychiatrists continue to prescribe daily orals, often citing patient acceptance as a major barrier. This fuels a cycle of oral nonadherence that often leads to relapse and loss.
Challenging engrained treatment behaviors: Disrupt the Decline Read More »
CASE STUDY: AUDIENCE TARGETING The Challenge MAVENCLAD positions itself as the Oral of Choice for first switch in Active RMS. The MS market is crowded with many sizable competitors, all fighting for the same patients. MAVENCLAD suffered a series of budget cuts that left the media budget at ~65% of initial OOP contract value ($13M vs $20M), below the spending
CASE STUDY: BEHAVIOR CHANGE The Challenge MAVENCLAD needed to find a way to stand out from the competition and expand paid social presence beyond Facebook & Instagram; TikTok was unchartered territory but represented an opportunity to be one of the first in the MS space to enter the platform. The Solution Launch unbranded TikTok program
Expanding the brand footprint into paid social Read More »
CASE STUDY: EMOTIONAL STORYTELLING The Challenge Branded Narcan was planning for commercial launch of a branded product in a complex generic market, at a time of unprecedented public health awareness and heightened collaborative efforts to solve the growing opioid epidemic in the United States. The brand believed that branded Narcan could be an important part of the broader
Infusing innovation with emotion to launch a one-of-a-kind product Read More »
The presentation outlines the importance of establishing an integrated approach in evidence generation to deliver a unified value proposition and discusses the challenges that an organisation must overcome when there is not such an approach in place. Finally, we lay out a set of benefits that pharmaceutical companies can realise from establishing of an IEGP
Integrated evidence generation planning (IEGP) Read More »